PIPELINE


Intezyne is developing a robust pipeline of product candidates offering the potential to target a range of disease areas.

ONCOLOGY INDICATION PRECLINICAL PHASE 1 PHASE 2 PHASE 3
IT-139
(GRP78 Inhibitor)
Combination Therapy

IT-139

IT-139

IT-141

IT-141

IT-141
(TOP-I Inhibitor)
Colorectal Cancer

IT-141

IT-141

IT-141

IT-141

IT-147 Solid Tumors

IT-147

IT-147

IT-147

IT-147


Strategic Overview


Strategic Overview.jpg

FDA Priority Review Programs